Literature DB >> 14679440

[Design and evaluation of the Extra Short Musculoskeletal Function Assessment Questionnaire XSMFA-D].

N Wollmerstedt1, S Kirschner, D Böhm, H Faller, A König.   

Abstract

AIM: The XSMFA-D (German Extra Short Musculoskeletal Function Assessment Questionnaire) was developed on the basis of the SMFA-D to provide a short questionnaire for assessment of the functional status from patient's perspective in routine use.
METHODS: Based on psychometric and medical aspects 16 items were extracted from the SMFA-D during an iterative process. 633 SMFA-D questionnaires of 199 patients were used as basic data. The XSMFA-D was evaluated on 67/51 patients with primary osteoarthritis of the knee/hip undergoing total joint replacement.
RESULTS: The tests for reliability and internal consistency produced favorable results. The Knee Score, Harris Hip Score, WOMAC and SMFA-D showed significant correlations to the XSMFA-D indicating construct validity. The criterion validity could be demonstrated successfully by relations with external parameters like walking distance, patients reported pain, mobility judgements by physicians and degree of osteoarthritis. The discriminant validity could also be demonstrated by significant differences between several different patient groups. Almost all effect sizes were generally large.
CONCLUSIONS: The XSMFA-D could be demonstrated to be an appropriate short questionnaire for the evaluation of therapy results from patient's perspective. The use of the XSMFA-D can be recommended for routine use. Further investigations of the instrument will be undertaken.

Entities:  

Mesh:

Year:  2003        PMID: 14679440     DOI: 10.1055/s-2003-812406

Source DB:  PubMed          Journal:  Z Orthop Ihre Grenzgeb        ISSN: 0044-3220


  6 in total

1.  Reliability, validity and responsiveness of the German Short Musculoskeletal Function Assessment Questionnaire in patients undergoing surgical or conservative inpatient treatment.

Authors:  Nicole Wollmerstedt; Stephan Kirschner; Herrmann Faller; Achim König
Journal:  Qual Life Res       Date:  2006-09-25       Impact factor: 4.147

2.  [A novel questionnaire to assess activity in patients after hip arthroplasties].

Authors:  N Wollmerstedt; U Nöth; F Mahlmeister; A Lotze; A Finn; J Eulert; C Hendrich
Journal:  Orthopade       Date:  2006-12       Impact factor: 1.087

3.  Effect of a Primary Care Management Intervention on Mental Health-Related Quality of Life Among Survivors of Sepsis: A Randomized Clinical Trial.

Authors:  Konrad Schmidt; Susanne Worrack; Michael Von Korff; Dimitry Davydow; Frank Brunkhorst; Ulrike Ehlert; Christine Pausch; Juliane Mehlhorn; Nico Schneider; André Scherag; Antje Freytag; Konrad Reinhart; Michel Wensing; Jochen Gensichen
Journal:  JAMA       Date:  2016-06-28       Impact factor: 56.272

Review 4.  Biologic and synthetic ligament reconstructions achieve better functional scores compared to osteosynthesis in the treatment of acute acromioclavicular joint dislocation.

Authors:  Maristella F Saccomanno; Giuseppe Sircana; Valentina Cardona; Valeria Vismara; Alessandra Scaini; Andrea G Salvi; Stefano Galli; Giacomo Marchi; Giuseppe Milano
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-08-14       Impact factor: 4.342

5.  Sepsis survivors monitoring and coordination in outpatient health care (SMOOTH): study protocol for a randomized controlled trial.

Authors:  Konrad Schmidt; Paul Thiel; Friederike Mueller; Katja Schmuecker; Susanne Worrack; Juliane Mehlhorn; Christoph Engel; Katja Brenk-Franz; Stephan Kausche; Ursula Jakobi; Anne Bindara-Klippel; Nico Schneider; Antje Freytag; Dimitry Davydow; Michel Wensing; Frank Martin Brunkhorst; Jochen Gensichen
Journal:  Trials       Date:  2014-07-11       Impact factor: 2.279

6.  Implications for post critical illness trial design: sub-phenotyping trajectories of functional recovery among sepsis survivors.

Authors:  Zudin A Puthucheary; Jochen S Gensichen; Aylin S Cakiroglu; Richard Cashmore; Lara Edbrooke; Christoph Heintze; Konrad Neumann; Tobias Wollersheim; Linda Denehy; Konrad F R Schmidt
Journal:  Crit Care       Date:  2020-09-25       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.